Abstract
At a university hospital in Japan, a total of 15 patients (14 adults and 1 newborn baby) with vancomycinresistant enterococci (VRE) infection or colonization (inf/col) were identified via routine clinical examinations and two nonroutine examinations from January to April 2007. Two case-control studies were conducted to identify the factors related to VRE inf/col. In study 1, the patients with VRE inf/col from ward A (n = 8) were compared with all of the patients without VRE isolates in the same ward, i.e., the controls (n = 26). In study 2, all adult patients with VRE inf/col throughout the hospital (n = 14) were compared with controls randomly selected from among all patients without VRE isolates (n = 45). All the subject cases were found to be infected or colonized with Enterococcus faecium, vanB. All but two of the isolated strains were completely identical according to pulsed field gel electrophoresis. Univariate analysis in study 2 showed several factors, including the isolation of methicillin-resistant Staphylococcus aureus (MRSA) (odds ratio [OR], 8.6; 95% confidence interval [CI], 1.3–53.7) and the use of antibiotics other than anti-MRSA drugs (OR, 33.0; 95% CI, 1.8–587.6) to be risk factors for VRE inf/col. Multivariate logistic regression analysis in study 2 demonstrated associations with VRE inf/col in the use of an ultrasound nebulizer (OR, 5.9; 95% CI, 1.5–22.8) and extended bed rest (OR, 3.8; 95% CI, 1.02–24.5). Although severe infection with VRE did not occur, to avoid the spread of VRE in hospital wards, further staff education should be implemented in regard to the usual standard and contact precautions, and the appropriate selection of antibiotics.
Similar content being viewed by others
References
Fujita N. Vancomycin-Resistant enterococci (VRE)-for VRE endemic in Japan (in Japanese). JARMAM (Rinsho Biseibutsu Jinsoku Shindan Kenkyukai Shi) 2005;16:1–16.
Fujimoto S, Takahashi A, Yomoda S, Murakami M, Ike Y. Vancomycin (VCM) resistant enterococci (VRE) (in Japanese). Nippon Rinsho 2003;61(Suppl 3):182–189.
Nikkei Telecom21. http://www.telecom21.co.jp (accessed on January 11, 2008).
Matsumoto T, Muratani T, Okada T, Shiraishi M, Hayashida T, Oki T, et al. No regional spread of vancomycin-resistant enterococci with vanA or vanB in Kitakyushu, Japan. J Infect Chemother 2004;10:331–334.
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.
Kahn HA, Sempos CT. Relative risk and odds ratio. In: Kahn HA, Sempos CT, editors. Statistical methods in epidemiology. New York: Oxford University Press; 1989. p. 45–71.
Damani NN. Vancomycin-resistant enterococci (VRE). Manual of infection control procedures. 2nd Ed. London: Greenwich Medical Media; 2003. p. 130–133.
Moriyama K, Tosaka N, Mimura S, Tokura A, Sunagawa T, Nakashima K, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance in hospital A in Japan (in Japanese with English abstract). Kankyokansen 2006;21:168–174.
Timmers GJ, van der Zwet WC, Simmon-Smit IM, Savelkoul PHM, Meester HH, Vandenbroucke-Grauls CMJE, et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of epidemic. Br J Haematol 2002;116:826–833.
MacIntyre CR, Empson M, Boardman C, Sindhusake D, Lokan J, Brown GV. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol 2001;22:624–629.
Furtado GHC, Mendes RE, Pignatari ACC, Wey SB, Medeiros EAS. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 2006;34:447–451.
Martinez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003;163:1905–1912.
Byers KE, Anglim AM, Anneski CJ, Germanson TP, Gold HS, Durbin LJ, et al. A hospital epidemic of vancomycin-resistant enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140–147.
Oishi T, Hitomi S, Shibuya S, Fukue H. Surveillance of vancomycin-resistant Enterococcus in hospitals in Ibaraki prefecture. J Infect Chemother 2004;10:125–127.
Nakatani H, Sano T, Iuchi T. Development of vaccination policy in Japan: current issues and policy directions. Jpn J Infect Dis 2002;55:101–111.
Surveillance data table, category V (notifiable disease). Infectious Disease Surveillance Center, National Institute of Infectious Disease. http://idsc.inh.go.jp/idwr/ydata/report-Ja.html (accessed on January 11, 2008).
VRE infection. http://idsc.inh.go.jp/idwr/kansen/k02_g1/k02_16/k02_16.html (accessed on January 11, 2008; in Japanese).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hoshuyama, T., Moriguchi, H., Muratani, T. et al. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies. J Infect Chemother 14, 354–360 (2008). https://doi.org/10.1007/s10156-008-0628-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-008-0628-x